Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
JANSSEN PHARMACEUTICALS, INC. et al v. WATSON LABORATORIES, INC. et al
Case Number:
2:08-cv-05103
Court:
Nature of Suit:
Judge:
Firms
- Eckert Seamans
- Fleming Ruvoldt
- Fox Rothschild
- Hill Wallack
- Holland & Knight
- Hunton Andrews
- Kenyon & Kenyon
- McCarter & English
- Stevens & Lee
Companies
Sectors & Industries:
-
September 11, 2012
J&J Wins Patent Dispute Over Birth Control Drug
A New Jersey federal judge Tuesday declared valid the patent behind Johnson & Johnson's Ortho Tri-Cyclen Lo birth control drug, blocking a Lupin Pharmaceuticals Inc. effort to market a generic competitor.
-
February 08, 2012
Watson, J&J Settle Over Birth Control Generic
Watson Laboratories on Wednesday announced that it has entered into an agreement with a Johnson & Johnson subsidiary by which the company will issue to Watson a generic version of J&J's Ortho Tri-Cyclen Lo birth control drug, days after the parties settled a related patent infringement suit in New Jersey.
-
January 25, 2011
Ortho Beats Watson Defenses In Birth Control IP Spat
Ortho-McNeil-Janssen Pharmaceuticals Inc. has beaten back two of Watson Laboratories Inc.'s affirmative defenses in its consolidated patent infringement suit seeking to block Watson and Lupin Pharmaceuticals Inc. from making a generic version of its Ortho Tri-Cyclen Lo contraceptive.